Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and uveal melanoma (mUM) at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

NEXT STORY
Immutep Announces Publication of AIPAC, TACTI-002 and TACTI-003 Abstracts for SITC 2021 Annual Meeting & AIPAC Global Webcast Details
PREV STORY
Quipt Continues National Expansion With Closing of Strategic Acquisition in Central Illinois and Ongoing Business Momentum as Respiratory Equipment Demand Remains Elevated Into Fiscal Q1 2022
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeiGene Receives Approval to Initiate Clinical Trials in China with PARP Inhibitor BGB-290

WALTHAM, Mass., Aug. 18, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

Inovio Doses 1st Subject in Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection

PLYMOUTH MEETING, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) ...

author_avatar
NASDAQ Market News

U.S. News and World Report Names University of Colorado Hospital to Best Hospitals Honor Roll

AURORA, Colo., Aug. 2, 2016 (GLOBE NEWSWIRE) -- For the first time, U.S. News ...

author_avatar
NASDAQ Market News